Aurora Cannabis (TSX:ACB) Surged 135% in 1 Week: Are Pot Stocks Back?

Last week, Aurora Cannabis Inc (TSX:ACB) surged 135%. What explains this totally unexpected rally?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

Last week, Aurora Cannabis (TSX:ACB)(NYSE:ACB) shares soared 135% in a single week, breaking a months-long downtrend. The rally occurred around the same time that the company announced it expected $64 million in sales in Q1. Aurora’s quarterly report for Q1 fiscal 2021 isn’t finalized, but people are still expecting the company to deliver solid results. If it does, then perhaps last week’s rally will continue into this week.

What explains the rally?

There are two theories widely circulating to explain Aurora’s massive rally last week:

  1. Upcoming earnings.
  2. Short-sellers covering their sales.

The first theory merits some explanation. Aurora is expecting to deliver $64 million in sales in Q1, which is down from $70 million in the same quarter a year ago and $72 million in the previous quarter. The expected sales decline looks bad on the surface. However, Aurora has spent much of 2020 spinning off business units, in a bid to strengthen its balance sheet. In this context, the lower revenue could be a positive. If Aurora’s revenue only declines slightly after it sells off unprofitable assets, then that may improve overall profitability. That would be an unambiguously positive development.

There’s also the theory that Aurora rallied due to short-sellers covering their positions. This theory was advanced by Keith Speights of Fool.com. When short-sellers buy back shares to cover their positions, that results in a short-lived rally. According to Speights, up to 19% of ACB shares were being sold short as of October 15. If that’s the case, then those short-sellers may have covered their positions later, leading to an illusory rally.

ACB is still losing money

Despite the optimism some feel toward Aurora Cannabis, the company still losing money. A lot of it. In fiscal 2020, the company had a staggering $3.3 billion net loss. That was partially due to non-cash factors like impairment, but even if you look at cash flow, the situation wasn’t good. ACB lost $337 million in cash from operations and also had net outflows from financing and investing activities.

The company’s upcoming quarterly report is going to be interesting in light of this. The reason why $64 million in revenue is being described as a positive is because it comes after several asset spinoffs. If Aurora can still bring in $64 million in sales after selling its underperforming businesses, then maybe it has a future ahead of it after all.

We’ll just have to wait and see. Aurora has had profitable quarters before, and there’s no reason it couldn’t have more ahead of it. But just like 2020’s massive losses were due to non-recurring factors, so were its previous profitable quarters. The company has generally lost money in terms of cash flow. So, despite last week’s gains, it’s far from certain that this company can turn its situation around.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »